Dihexa FAQ for Laboratory Researchers
Dihexa is an oligopeptide derivative derived from angiotensin IV that has drawn significant interest in neurobiology and synaptogenesis research. This technical FAQ provides principal investigators and laboratory staff with verified technical specifications, handling protocols, analytical metrics, and sourcing standards for conducting robust in vitro and animal model investigations.
Quick answer
Dihexa is an oligopeptide derivative derived from angiotensin IV that has drawn significant interest in neurobiology and synaptogenesis research. This technical FAQ provides principal investigators and laboratory staff with verified technical specifications, handling protocols, analytical metrics, and sourcing standards for conducting robust in vitro and animal model investigations.
Key takeaways
- [Dihexa](/research-peptides/dihexa) (chemical formula: C27H44N4O5, molecular weight: 504.66 g/mol), also recognized in academic literature as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) or PNSB-1014, is a orally active, lipophilic hexapeptide fragment analogue.
- Preclinical data indicate that [Dihexa](/research-peptides/dihexa) functions as a potent small-molecule agonist of the HGF/c-Met receptor system.
- To ensure reproducible experimental outcomes, every production lot of [Dihexa](/research-peptides/dihexa) synthesized for PX1 Research undergoes rigorous testing in an ISO 17025 accredited laboratory.
- Bacterial endotoxins (lipopolysaccharides, or LPS) present a severe confounding variable in neurobiological research.
Overview and Chemical Architecture of Dihexa
Dihexa (chemical formula: C27H44N4O5, molecular weight: 504.66 g/mol), also recognized in academic literature as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) or PNSB-1014, is a orally active, lipophilic hexapeptide fragment analogue. Unlike traditional short-chain peptides that exhibit rapid enzymatic degradation in biological matrices, Dihexa was structurally engineered with an N-terminal hexanoyl chain and modified peptide bonds to enhance metabolic stability and cellular permeability during preclinical research.
When purchasing compounds for institutional studies, researchers can access the complete Dihexa research peptide profile through our core inventory. In laboratory settings, Dihexa is primarily investigated for its high-affinity interaction with hepatocyte growth factor (HGF) and its receptor, c-Met, serving as a primary tool to evaluate dendritic spine formation, synaptic plasticity, and neuroprotective cascades in established cell cultures and rodent models.
Molecular Target and Signal Transduction Pathways
Preclinical data indicate that Dihexa functions as a potent small-molecule agonist of the HGF/c-Met receptor system. In vitro binding assays demonstrate that Dihexa binds to biological HGF with high affinity, dimerization-dependent activation of the c-Met receptor tyrosine kinase pathway. Upon binding, c-Met undergoes autophosphorylation, initiating downstream signaling cascades including the MAPK/ERK and PI3K/Akt pathways.
Researchers evaluating synaptic density observe that activation of these downstream signals promotes spinogenesis and synaptogenesis in primary hippocampal and cortical neuron cultures. Comparative in vitro assays demonstrate that Dihexa induces dendritic arborization at picomolar concentrations, making it a critical reference standard in structural neurobiology research. Researchers can explore broader background literature in our research library hub to evaluate how c-Met signaling intersects with other pathway targets.
Analytical Standards: HPLC/MS and COA Verification
To ensure reproducible experimental outcomes, every production lot of Dihexa synthesized for PX1 Research undergoes rigorous testing in an ISO 17025 accredited laboratory. Analytical evaluation relies on High-Performance Liquid Chromatography (HPLC) coupled with Mass Spectrometry (MS) to verify both chemical purity and exact molecular mass.
A valid Certificate of Analysis (COA) must accompany all research-grade reagents. The HPLC chromatogram establishes peptide purity—mandating a minimum threshold of 98.0%—by resolving trace impurities, truncated sequences, or residual organic solvents. Simultaneously, Electrospray Ionization Mass Spectrometry (ESI-MS) confirms the single molecular ion peak corresponding to the theoretical mass of Dihexa. Researchers requiring lot-specific documentation can review our HPLC and Mass Spectrometry documentation protocols.
Endotoxin Limits and Quality Assurance Standards
Bacterial endotoxins (lipopolysaccharides, or LPS) present a severe confounding variable in neurobiological research. Microglial activation triggered by trace endotoxins can artifactually alter gene expression, cytokine secretion, and synaptic remodeling, distorting experimental data.
PX1 Research enforces strict quality control standards, subjecting all synthesized lots to Chromogenic Reconstitution Limulus Amebocyte Lysate (LAL) testing. All lots of Dihexa meet stringent endotoxin thresholds (<0.05 EU/mg), ensuring that cellular responses observed in culture or animal tissue models reflect true peptide activity rather than inflammatory contamination. Detailed quality metrics are detailed in our overview of endotoxin testing protocols.
Solubility, Reconstitution, and Vehicle Compatibility
Dihexa possesses distinct physicochemical properties compared to hydrophilic peptides. Due to its hexanoyl chain and hydrophobic amino acid residues, lyophilized Dihexa exhibits limited solubility in pure aqueous solutions at neutral pH. Standard laboratory protocols require pre-solubilization in organic vehicles such as Dimethyl Sulfoxide (DMSO) or Ethanol (EtOH) prior to aqueous dilution.
For cell culture assays, a common stock solution is prepared by dissolving lyophilized Dihexa powder in 100% molecular biology grade DMSO to achieve a concentration of 10 mM to 50 mM. This stock can then be diluted into sterile phosphate-buffered saline (PBS) or culture media, maintaining a final DMSO concentration below 0.1% (v/v) to avoid vehicle-induced cytotoxicity. For additional practical preparation guidance, review our standardized peptide reconstitution guidelines.
Lyophilization, Storage Conditions, and Stability Metrics
Lyophilized Dihexa is delivered in sealed, vacuum-packed amber glass vials to protect the compound from photo-degradation and moisture intrusion. When stored in its solid state at -20°C or -80°C in a desiccated environment, Dihexa maintains structural integrity and biological activity for up to 24 months.
Upon reconstitution, liquid stock solutions stored in DMSO or organic vehicles should be divided into single-use aliquots to prevent repeated freeze-thaw cycles, which degrade peptide bonds over time. Aliquoted DMSO stocks remain stable at -80°C for up to 6 months. Aqueous working solutions should be prepared immediately prior to experimental administration and maintained at 4°C for no longer than 24 to 48 hours.
In Vitro and Preclinical Research Applications
In vitro investigation of Dihexa routinely focuses on organotypic hippocampal slice cultures, primary rodent neuronal cultures, and human induced pluripotent stem cell (iPSC)-derived neurons. Investigators monitor parameters such as dendritic spine density, post-synaptic density protein 95 (PSD-95) expression, and neurite outgrowth lengths following treatment across picomolar to nanomolar concentration gradients.
In vivo preclinical research involving rodent models assesses Dihexa's capacity to cross the blood-brain barrier following systemic administration. Preclinical studies suggest that because of its lipophilic character, Dihexa achieves neural tissue accumulation, where it acts upon c-Met receptors to stimulate central synaptogenesis. Researchers studying broader cognitive mechanisms can also evaluate related neuroactive peptides across our catalog.
Comparative Analysis: Dihexa and Related Research Oligopeptides
When designing comparative neurological models, investigators frequently evaluate Dihexa alongside other bench reference peptides targeting cognitive, neuroprotective, or trophic pathways. While Dihexa selectively acts via HGF/c-Met dimerization, compounds like Semax and Selank modulate central BDNF expression, monoaminergic systems, and GABAergic signaling. Similarly, modified derivatives such as N-Acetyl Semax Amidate offer altered metabolic half-lives and enhanced peptide stability in enzymatic assays. Dihexa remains distinct in this class due to its exceptionally high potency at picomolar ranges and its primary mechanism rooted in structural synaptogenesis.
Understanding these mechanistic divergences allows principal investigators to select the precise tool compound required for their specific neurobiological hypothesis—whether studying acute signaling cascades, neuroinflammation, or long-term structural plasticity.
USA Synthesis, Facility Compliance, and Lab Procurement
All Dihexa supplied by PX1 Research is synthesized in state-of-the-art facilities within the United States, operating under strict Good Manufacturing Practice (GMP) compliance guidelines. USA synthesis ensures complete traceability of raw materials, elimination of cross-contamination risks, and rigorous process control at every synthetic step.
Academic laboratories, biotechnology firms, and contract research organizations (CROs) requiring multi-gram quantities or specialized custom fill sizes can set up bulk lab accounts to secure dedicated lot reservation and volume-tiered institutional pricing. Orders ship directly from our centralized distribution hubs in California and Arizona, with same-day dispatch for orders confirmed Monday through Friday.
Frequently Asked Questions
What is Dihexa and what is its primary target in laboratory research?
Dihexa (PNSB-1014) is a synthetic hexapeptide analogue derived from angiotensin IV. Its primary molecular target in preclinical research is Hepatocyte Growth Factor (HGF) and its receptor c-Met, where it acts as a potent agonist to stimulate spinogenesis and synaptogenesis.
How is the purity of Dihexa verified by PX1 Research?
PX1 Research verifies every lot of Dihexa through an independent, ISO 17025 accredited laboratory using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). Purity must meet or exceed 98.0%, and a lot-specific Certificate of Analysis (COA) is provided.
What are the standard endotoxin limits for PX1 Research Dihexa?
All research-grade Dihexa undergoes LAL chromogenic testing to confirm endotoxin levels remain strictly under <0.05 EU/mg. This prevents non-specific neuroinflammatory artifacts during cell culture and tissue assays.
How should lyophilized Dihexa be stored upon arrival?
Lyophilized Dihexa should be stored in a freezer at -20°C or -80°C in a desiccated container protected from light. Under these conditions, the powder remains stable for up to 24 months.
What solvent is recommended for reconstituting Dihexa?
Due to its lipophilic structure, Dihexa should first be reconstituted in 100% DMSO or Ethanol to prepare a concentrated stock (e.g., 10–50 mM). This stock can then be diluted into aqueous buffers like PBS, ensuring final solvent concentration does not exceed cell viability limits (typically <0.1% v/v).
How long are reconstituted Dihexa stock solutions stable?
Liquid stock solutions dissolved in pure DMSO remain stable at -80°C in single-use aliquots for up to 6 months. Diluted aqueous working solutions should be prepared fresh and used within 24 to 48 hours when kept at 4°C.
Is Dihexa soluble directly in water or saline?
No, Dihexa exhibits poor direct solubility in pure water or physiological saline at neutral pH due to its N-terminal hexanoyl group. Pre-solubilization in an organic solvent such as DMSO is necessary.
What concentration range is typically evaluated in in vitro neuronal assays?
In vitro studies published in peer-reviewed literature frequently evaluate Dihexa across picomolar (10^-12 M) to nanomolar (10^-9 M) ranges to measure dendritic arborization, spine density, and c-Met autophosphorylation.
How does Dihexa compare mechanically to Semax or Selank?
Dihexa primarily acts by binding HGF and activating c-Met tyrosine kinase signaling to induce structural synaptogenesis. In contrast, Semax and Selank act predominantly via BDNF upregulation, monoaminergic modulation, and GABAergic pathway regulation.
Where is PX1 Research Dihexa synthesized and shipped from?
PX1 Research Dihexa is synthesized in cGMP-compliant facilities located in the United States. Orders ship directly from our dispatch centers in California and Arizona with same-day fulfillment for orders placed Monday through Friday.
Can institutional buyers obtain bulk quantities of Dihexa?
Yes, universities, CROs, and institutional laboratories can establish wholesale accounts to obtain bulk quantities, reserved lot numbers, and customized packaging sizes.
Are PX1 Research compounds intended for human clinical use?
No. All products supplied by PX1 Research, including Dihexa, are strictly for laboratory research, in vitro investigation, and preclinical research use only. They are not for human or animal therapeutic use, administration, or consumption.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.